Scientists Uncover How Vitamin A Signal Helps Tumors Evade Immune Attack
Scientists have identified a hidden vitamin A-related signal that helps cancers evade the immune system, and developed a way to switch it off. Researchers at the Princeton University branch of the Ludwig Institute for Cancer Research report that a vitamin A-derived molecule, all-trans retinoic acid, can suppress key immune responses against tumors and undermine the effectiveness of certain cancer vaccines. The findings, detailed in two studies published in Nature Immunology and iScience, help resolve a long-standing scientific debate over vitamin A's mixed role in cancer. They also led to the development of the first experimental drugs designed to block retinoic acid signaling, a pathway that had resisted drug development for decades.

